Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Hisse Senetlerindeki Sıralama #17188
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Hisse Fiyatı
$2.20
Son senkronizasyon: 2026-09-01
Piyasa Değeri
$253.81M
Değişim (1 gün)
10.29%
Değişim (1 yıl)
99.67%
Ülke
CA
Ticaret Cardiol Therapeutics Inc. (CRDL)

Kategori

Cardiol Therapeutics Inc. (CRDL) için hisse bölünme geçmişi
Cardiol Therapeutics Inc. hissesi (sembol: CRDL) toplamda 0 hisse bölünmesi yaşamıştır.
En son hisse bölünmesi Sep 02, 2026 tarihinde gerçekleşmiştir.
Sep 02, 2026 tarihinden önce alınan bir CRDL hissesi bugün 0 CRDL hissesine eşdeğerdir.
Hisse bölünme listesi
Yıl Bölünme Çarpan Kümülatif Çarpan
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için hisse bölünmeleri